Facebook  Twitter  Youtube  ISSUU  RSS  Email

Media Contacts

UK
Press Office
press@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office journalists Letter Leveson Inquiry London Merkel metropolitan police moneylaundering money laundering offshore tax open governance pharmaceuticals PHP police ethics Prime Minister Register of Interests Research safe havens Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Twitter

TransparencyUK This also raises broader questions for the UK’s agencies tackling suspicious wealth. Our full statement: https://t.co/ZoD6P12yDo
3hreplyretweetfavorite
TransparencyUK RT @BenCowdock: An investigation by @TransparencyUK @FinUncovered and @OCCRP in today's @ObserverUK shines a light on UK assets worth £50m…
4hreplyretweetfavorite
TransparencyUK This investigation adds to the overwhelming weight of evidence that the UK has become a safe haven for suspicious w… https://t.co/NPJJ4oBM61
4hreplyretweetfavorite

Stay Informed

Sign up for updates on Transparency International UK's work,corruption news from around the world and fundraising and events updates.

Recent Blog Posts

Search Blog

James Sale

James is TI-UK's Project Officer heading the Pharmaceutical and Healthcare Programme. You can follow the programme on Twitter @TIUK_Health.

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.

Tuesday, 10 February 2015 12:00

Lobbying the NHS

In February 2014 the UK media claimed that NHS England had, despite prior knowledge, invited a patients group entirely funded by the pharmaceutical industry and headed by a well-known pharmaceutical industry lobbyist to draft a report which could affect future NHS policy. The group is called the Specialised Healthcare Alliance and its Director, John Murray, also heads a lobbying firm whose clients include some of the world’s biggest drug and medical device firms.

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of